These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 22497963)
1. Predictors of septic shock in patients with methicillin-resistant Staphylococcus aureus bacteremia. Lam SW; Bauer SR; Neuner EA Int J Infect Dis; 2012 Jun; 16(6):e453-6. PubMed ID: 22497963 [TBL] [Abstract][Full Text] [Related]
2. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610 [TBL] [Abstract][Full Text] [Related]
3. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients. Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238 [TBL] [Abstract][Full Text] [Related]
4. Comparison of microbiological and clinical characteristics based on SCCmec typing in patients with community-onset meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia. Kuo SC; Chiang MC; Lee WS; Chen LY; Wu HS; Yu KW; Fung CP; Wang FD Int J Antimicrob Agents; 2012 Jan; 39(1):22-6. PubMed ID: 21982834 [TBL] [Abstract][Full Text] [Related]
5. Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology. Schreiber MP; Chan CM; Shorr AF J Crit Care; 2011 Aug; 26(4):395-401. PubMed ID: 21036521 [TBL] [Abstract][Full Text] [Related]
7. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Hanberger H; Walther S; Leone M; Barie PS; Rello J; Lipman J; Marshall JC; Anzueto A; Sakr Y; Pickkers P; Felleiter P; Engoren M; Vincent JL; Int J Antimicrob Agents; 2011 Oct; 38(4):331-5. PubMed ID: 21798720 [TBL] [Abstract][Full Text] [Related]
8. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Healy CM; Hulten KG; Palazzi DL; Campbell JR; Baker CJ Clin Infect Dis; 2004 Nov; 39(10):1460-6. PubMed ID: 15546082 [TBL] [Abstract][Full Text] [Related]
9. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. Yoon YK; Kim JY; Park DW; Sohn JW; Kim MJ J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Fowler VG; Justice A; Moore C; Benjamin DK; Woods CW; Campbell S; Reller LB; Corey GR; Day NP; Peacock SJ Clin Infect Dis; 2005 Mar; 40(5):695-703. PubMed ID: 15714415 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan. Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366 [TBL] [Abstract][Full Text] [Related]
12. Adult methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: clinical significance of non-multi-resistant antibiogram and Panton-Valentine leukocidin gene. Wang JL; Wang JT; Chen SY; Hsueh PR; Kung HC; Chen YC; Chang SC Diagn Microbiol Infect Dis; 2007 Dec; 59(4):365-71. PubMed ID: 17878063 [TBL] [Abstract][Full Text] [Related]
13. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Soriano A; Marco F; MartÃnez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250 [TBL] [Abstract][Full Text] [Related]
14. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Kullar R; Davis SL; Levine DP; Rybak MJ Clin Infect Dis; 2011 Apr; 52(8):975-81. PubMed ID: 21460309 [TBL] [Abstract][Full Text] [Related]
16. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781 [TBL] [Abstract][Full Text] [Related]
17. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Kopp BJ; Nix DE; Armstrong EP Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044 [TBL] [Abstract][Full Text] [Related]
18. Outcomes and costs associated with a history of vancomycin exposure in patients with MRSA-related complicated bacteremia and infective endocarditis. Brown J; Brown KA; Forrest A Clin Ther; 2011 Oct; 33(10):1475-82. PubMed ID: 21925733 [TBL] [Abstract][Full Text] [Related]
19. The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia. Han JH; Edelstein PH; Bilker WB; Lautenbach E J Infect; 2013 Jan; 66(1):41-7. PubMed ID: 22960078 [TBL] [Abstract][Full Text] [Related]
20. Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome. Fang CT; Shau WY; Hsueh PR; Chen YC; Wang JT; Hung CC; Huang LY; Chang SC J Antimicrob Chemother; 2006 Mar; 57(3):511-9. PubMed ID: 16443700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]